Omar S Aljitawi, M.D

Hematology-Oncology

University of Rochester

ROCHESTER, NY

Last updated· May 2026 PI on 1 trialNPI: 1013018415

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
Aplastic Anemia

Clinical trials (1)

NCT03964506

Verify independently

ClinicalTrials.gov PI search for Omar S Aljitawi
NPPES NPI registry entry

Other specialists for Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent

Peers ranked by clinical-trial PI role, publications, and verification quality.

He Huang
The First Affiliated Hospital
Jaroslaw P Maciejewski, MD
Cleveland Clinic
OH
Boehringer Ingelheim
The Institute for Liver Health II DBA Arizona Clinical Trials
Arizona
Jorge Cortes, MD
UT MD Anderson Cancer Center
Bristol Myers Squibb
Bristol-Myers Squibb
Horst Olschewski, MD
Medical University of Graz
Elias Jabbour, MD, M.D
M.D. Anderson Cancer Center
TX
Farhad Ravandi-Kashani, MD, M.D
M.D. Anderson Cancer Center
TX

See all specialists for Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent →

← Back to specialists directory